@jonepstein1 I don’t even need a second person to be involved for there to be a bit of a conflict Generic names are better & trained as a clinical pharmacologist, I generally believe therapeutic & bio-equivalence are robust But the more I learn,
So far, Altmetric has seen
410 X posts from 336 X users, with an upper bound of 2,041,318 followers.
4,897 followers
4,897 followers
4,897 followers
@DanielJDrucker @US_FDA We wrote about this: https://t.co/gVpRKUaQHl What bothers me is we wrote an update here on data FDA released >year ago on their testing of ARBs https://t.co/wAWQvAYPuU & no updates since from FDA, in over a year. & if y
4,897 followers
RT @GenNextMD: 6. Recall of ARB - nightmare for patients as well as clinicians over the summer of 2019 @NEJM https://t.co/1VClwzrY7g @theb…